European Biotech Acquisition - Warrants (06/03/2026)'s current cash is $310K.
Get informed when a big investor buys or sells
+ FollowLatest change versus the prior comparable period (same company).
As of the most recent data (December 2022), EBACW shows a current cash of $310K. That compares with $870K in the prior-year period — down 64.5% year over year. Scroll down for historical charts and peer comparison views.
Compared with the year-ago period, EBACW's current cash is now $310K (was $870K) — a 64.5% year-over-year decrease. Pairing that YoY change with peer averages gives a clearer picture of whether European Biotech Acquisition - Warrants (06/03/2026) is outperforming or lagging.
Tracking EBACW's current cash over time shows whether European Biotech Acquisition - Warrants (06/03/2026) is scaling, shrinking, or reshaping that part of the business. The current reading is $310K That compares with $870K in the prior-year period — down 64.5% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.
Besides this current cash page, Stockcircle has European Biotech Acquisition - Warrants (06/03/2026)'s full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect current cash (currently $310K) with ownership activity and broader fundamentals.